TZP-101 (ulimorelin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TZP-101 (ulimorelin), covering 2024-09-19 to 2024-09-19. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety of Post-Operative TZP-101 (IV Ulimorelin) After Partial Bowel Resection [Phase 3]